UNSPSC 51283102: Caspofungin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0XDI6ZL63. European Medicines Agency schedules Caspofungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16405MIG. Caspofungin generally arises in the molecular formula C52H88N10O15. The term CASPOFUNGIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 no. 3, 1999, list 42.) Most nations schedule caspofungin under HS 29419000 and SITC 54139.

As of Q4 2014, CASPOFUNGIN remains the US FDA Preferred Term for this commodity. Caspofungin bears US NLM identifiers UMLS ID C0537894 and NCI Concept Code C28910. SMILES: OC1C2N(CC1)C(=O)C(NC(=O)C(NC(=O)C1N(CC(O)C1)C(=O)C(NC(=O)C(NC(=O)CCCCCCCCC(CC(CC)C)C)CC(O)C(NC2=O)NCCN)C(O)C)C(O)C(O)C1CCC(O)CC1)C(O)CCN.

UNSPSC 51283102 Caspofungin is a Commodity code nominally describing a specific antifungal pharmaceutical, but recent state and local solicitations tagged with this code show a significant mismatch between the code's scope and actual procurement activity. The opportunities posted under this code involve naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs — none of which are caspofungin specifically. The code appears to have been applied incorrectly to these opportunities, which span emergency medical supplies, pharmacy benefit management, and broader pharmaceutical procurement rather than procurement of a single antifungal agent. Issuing bodies include a county health department (Seminole County, Florida), a municipal fire department (City of Tampa), a state health and human services commission (Texas HHS), and a multistate cooperative purchasing alliance (MMCAP administered by Minnesota Department of Administration).

Recent activity is geographically distributed across Florida, Texas, and the Upper Midwest through the MMCAP cooperative. Representative opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems; the City of Tampa's bid 26-P-00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies to the Tampa Fire Department with an estimated contract value of $700,000 and a small local business enterprise set-aside; the Minnesota MMCAP RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers; and Texas HHS's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs. The code shows little relevant recent activity aligned with caspofungin procurement and should not be relied upon for forecasting demand in antifungal pharmaceutical supply.